HONGXIN HE: Open Payments
NPI 1770639593 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,551 in 72 payments from 16 companies in 2025. Trend: 2023 $1,792 · 2024 $1,394 · 2025 $3,551
Food & beverage: $3,551
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 18 | $1,838 |
| Regeneron Healthcare Solutions, Inc. | 9 | $352 |
| GlaxoSmithKline, LLC. | 15 | $268 |
| GENZYME CORPORATION | 6 | $190 |
| Amgen Inc. | 5 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Abbott Laboratories | 1 | $139 |
| ACADIA Pharmaceuticals Inc | 1 | $92 |
| Verona Pharma, Inc. | 3 | $84 |
| PFIZER INC. | 1 | $83 |
Products named: Leqembi, DUPIXENT, NUCALA, INFINITY, KRYSTEXXA, AIRSUPRA, FABRAZYME, NUPLAZID.
Industry payments across CA — which companies pay providers there.
